Rosuvastatin effectively lowers LDL by inhibiting cholesterol synthesis, ideal for severe hyperlipidemia. Ezetimibe, reducing intestinal cholesterol absorption, suits patients intolerant to statins.

Ezetimibe targets cholesterol absorption, presenting fewer side effects, beneficial for statin-sensitive patients. Rosuvastatin offers potent LDL reduction, recommended for aggressive lipid management.

Rosuvastatin is highly potent in reducing LDL levels and cardiovascular risk. Ezetimibe is typically used when statins are not enough or for statin intolerance, adding flexibility in treatment plans.